Skip to main content

NOACs for Stroke Prevention in Atrial Fibrillation - .75 CME Credits

NOAC efficacy, safety, and selection

Start Date: Nov 20, 2018
Duration: ~ 45 minutes
Price: $35

Course Description

This course will review the clinical trial data on the efficacy and safety of non-vitamin K oral anticoagulants (NOACs) for prevention of stroke in patients with atrial fibrillation (AF). We will cover the appropriate dosing and monitoring of NOACs and their appropriate use in different vulnerable patient populations. This course will also review strategies to prevent and manage NOAC-related bleeding in the era of specific reversal agents (antidotes).

This course is intended for primary care and specialty physicians, pharmacists, psychologists, physician assistants, nurses, and nurse practitioners.

What You'll Learn

  • Review the clinical trial data on the efficacy and safety of NOACs compared with warfarin for preventing strokes in patients with AF
  • Identify correct NOAC dosing and the role of routine monitoring
  • Describe strategies to prevent and manage NOAC-related bleeding in the era of specific reversal agents

Want to purchase this course for a group?

You can purchase enrollment codes for this course to distribute to your team

Purchase for a Group

Instructors

Christian T. Ruff, MD, MPH

Christian T. Ruff, MD, MPH Assistant Professor of Medicine, Harvard Medical School; Director of General Cardiology, Cardiovascular Division, Brigham and Women’s Hospital; Investigator, TIMI Study Group

COURSE OUTLINE

NOACs for Stroke Prevention in Atrial Fibrillation is organized as follows:

Precourse Information:
Accreditation and AMA Credit Designation
Disclosure Statement
How to Take This Course
Viewing Videos
Grading and Certificates

NOACs for Stroke Prevention in Atrial Fibrillation
Overview
Dosing and Monitoring
NOAC-Related Bleeding
Selecting a NOAC

CME Certificate
CME Posttest
Course Evaluation

ACCREDITATION AND AMA CREDIT DESIGNATION STATEMENTS

ACCREDITATION STATEMENT

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT

The Harvard Medical School designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC APPROVAL STATEMENT

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Every 30 days HMS GCE will upload participant data (name, date of birth, ABIM ID#, MOC points earned) for any learners who have completed this activity directly to their transcript at the ABIM via the ACCME's Program and Activity Reporting System (PARS). Since MOC points earned will be uploaded to your ABIM transcript these points will not appear on your CME certificate. If you do not see your points on your ABIM transcript after 30 days of completing the activity please contact Jillian West at HMS GCE at jillian_west@hms.harvard.edu.

DISCLOSURE STATEMENT

Disclosure Policy

Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of the activity) consumed by, or used on, patients:

Name: Christian Ruff, MD
Role: Faculty/Speaker
Company: Daiichi Sankyo
Relationship: Grant, Research Support, Consultant, Advisory Board
Company: MedImmune
Relationship: Grant, Research Support
Company: Bayer
Relationship: Consultant, Advisory Board
Company: Boehringer Ingelheim
Relationship: Consultant, Advisory Board
Company: Janssen
Relationship: Consultant, Advisory Board
Company: Portola
Relationship: Consultant, Advisory Board

Name: Louis Pasquale, MD
Role: CME Committee Member and Reviewer
Company: Bausch + Lomb
Relationship: Paid Consultant
Company: Novartis
Relationship: Non-paid consultant
Company: Allergan
Relationship: Speaker
Company: Merck
Relationship: Unrestricted Grant

     

All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.

COURSE DIRECTOR

J. Kevin Tucker, M.D., is an associate physician at Brigham and Women’s Hospital and assistant professor of medicine at Harvard Medical School. He is also the chief of nephrology at Brigham and Women’s/Faulkner Hospital and faculty director for accreditation and MOC in the Department of Postgraduate Medical Education at Harvard Medical School. Dr. Tucker received his undergraduate education at Birmingham-Southern College and completed his medical education at Cornell University Medical College. He trained in internal medicine at Massachusetts General Hospital and in nephrology at the University of Alabama at Birmingham. His clinical interests include chronic kidney disease, hemodialysis, and peritoneal dialysis.

FREQUENTLY ASKED QUESTIONS

How long will this course take?

This course should take approximately 45 minutes to complete. You do not need to complete it all at once. You may come back as often as you like.

How long will this course be available?

This self-paced course will close enrollments one year after its start date.

What web browser should I use?

The platform works best with current versions of Chrome, Firefox, or Safari, or with Internet Explorer version 11 and above. See our list of supported browsers for the most up-to-date information.

What if I want to learn more about this topic?

HMS Continuing Education holds live topic-focused conferences throughout the year. Please see our course catalog for upcoming events.

Enroll